newsfilter
← Latest News
GlobeNewswire·

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that for the full year of 2023, its unaudited revenues have grown from $9.4M in 2022 to